These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23461361)

  • 1. Gemcitabine-coumarin-biotin conjugates: a target specific theranostic anticancer prodrug.
    Maiti S; Park N; Han JH; Jeon HM; Lee JH; Bhuniya S; Kang C; Kim JS
    J Am Chem Soc; 2013 Mar; 135(11):4567-72. PubMed ID: 23461361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate-based near-infrared fluorescent theranostic gemcitabine delivery.
    Yang Z; Lee JH; Jeon HM; Han JH; Park N; He Y; Lee H; Hong KS; Kang C; Kim JS
    J Am Chem Soc; 2013 Aug; 135(31):11657-62. PubMed ID: 23865715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct fluorescence monitoring of the delivery and cellular uptake of a cancer-targeted RGD peptide-appended naphthalimide theragnostic prodrug.
    Lee MH; Kim JY; Han JH; Bhuniya S; Sessler JL; Kang C; Kim JS
    J Am Chem Soc; 2012 Aug; 134(30):12668-74. PubMed ID: 22642558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fluorescence off-on reporter for real time monitoring of gemcitabine delivery to the cancer cells.
    Bhuniya S; Lee MH; Jeon HM; Han JH; Lee JH; Park N; Maiti S; Kang C; Kim JS
    Chem Commun (Camb); 2013 Aug; 49(64):7141-3. PubMed ID: 23831834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System.
    Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P
    Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A facile route to heterotelechelic polymer prodrug nanoparticles for imaging, drug delivery and combination therapy.
    Vinciguerra D; Denis S; Mougin J; Jacobs M; Guillaneuf Y; Mura S; Couvreur P; Nicolas J
    J Control Release; 2018 Sep; 286():425-438. PubMed ID: 30099018
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis, crystallization, and biological evaluation of an orally active prodrug of gemcitabine.
    Bender DM; Bao J; Dantzig AH; Diseroad WD; Law KL; Magnus NA; Peterson JA; Perkins EJ; Pu YJ; Reutzel-Edens SM; Remick DM; Starling JJ; Stephenson GA; Vaid RK; Zhang D; McCarthy JR
    J Med Chem; 2009 Nov; 52(22):6958-61. PubMed ID: 19860433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H-gemcitabine: a new gemcitabine prodrug for treating cancer.
    Dasari M; Acharya AP; Kim D; Lee S; Lee S; Rhea J; Molinaro R; Murthy N
    Bioconjug Chem; 2013 Jan; 24(1):4-8. PubMed ID: 23237198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disulfide-based multifunctional conjugates for targeted theranostic drug delivery.
    Lee MH; Sessler JL; Kim JS
    Acc Chem Res; 2015 Nov; 48(11):2935-46. PubMed ID: 26513450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Fluorescent Gemcitabine Prodrug That Follows a Nucleoside Transporter-Independent Internalization and Bears Enhanced Therapeutic Efficacy With Respect to Gemcitabine.
    Vrettos EΙ; Kyrkou SG; Zoi V; Giannakopoulou M; Chatziathanasiadou MV; Kanaki Z; Agalou A; Bistas VP; Kougioumtzi A; Karampelas T; Diamantis DA; Murphy C; Beis D; Klinakis A; Tamvakopoulos C; Kyritsis AP; Alexiou GA; Tzakos AG
    Chemistry; 2024 Sep; 30(50):e202401327. PubMed ID: 38941241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of Gemcitabine-Threonine Amide Prodrug Effective on Pancreatic Cancer Cells with Improved Pharmacokinetic Properties.
    Hong S; Fang Z; Jung HY; Yoon JH; Hong SS; Maeng HJ
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30314360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemcitabine-camptothecin conjugates: a hybrid prodrug for controlled drug release and synergistic therapeutics.
    Hou M; Xue P; Gao YE; Ma X; Bai S; Kang Y; Xu Z
    Biomater Sci; 2017 Aug; 5(9):1889-1897. PubMed ID: 28681888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational design of biotin-disulfide-coumarin conjugates: a cancer targeted thiol probe and bioimaging.
    Jung D; Maiti S; Lee JH; Lee JH; Kim JS
    Chem Commun (Camb); 2014 Mar; 50(23):3044-7. PubMed ID: 24510148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced anticancer activity of gemcitabine coupling with conjugated linoleic acid against human breast cancer in vitro and in vivo.
    Tao XM; Wang JC; Wang JB; Feng Q; Gao SY; Zhang LR; Zhang Q
    Eur J Pharm Biopharm; 2012 Oct; 82(2):401-9. PubMed ID: 22728546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmembrane diffusion of gemcitabine by a nanoparticulate squalenoyl prodrug: an original drug delivery pathway.
    Bildstein L; Dubernet C; Marsaud V; Chacun H; Nicolas V; Gueutin C; Sarasin A; Bénech H; Lepêtre-Mouelhi S; Desmaële D; Couvreur P
    J Control Release; 2010 Oct; 147(2):163-70. PubMed ID: 20691740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-Initiated Synthesis of Heterotelechelic Polymer Prodrug Nanoparticles for in Vivo Imaging and Cancer Cell Targeting.
    Vinciguerra D; Degrassi A; Mancini L; Mura S; Mougin J; Couvreur P; Nicolas J
    Biomacromolecules; 2019 Jul; 20(7):2464-2476. PubMed ID: 31150219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An activatable theranostic for targeted cancer therapy and imaging.
    Bhuniya S; Maiti S; Kim EJ; Lee H; Sessler JL; Hong KS; Kim JS
    Angew Chem Int Ed Engl; 2014 Apr; 53(17):4469-74. PubMed ID: 24644015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of programmable gemcitabine-GnRH pro-drugs bearing linker controllable "click" oxime bond tethers and preclinical evaluation against prostate cancer.
    Vrettos EI; Karampelas T; Sayyad N; Kougioumtzi A; Syed N; Crook T; Murphy C; Tamvakopoulos C; Tzakos AG
    Eur J Med Chem; 2021 Feb; 211():113018. PubMed ID: 33223264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pH-responsive prodrug for real-time drug release monitoring and targeted cancer therapy.
    Li SY; Liu LH; Jia HZ; Qiu WX; Rong L; Cheng H; Zhang XZ
    Chem Commun (Camb); 2014 Oct; 50(80):11852-5. PubMed ID: 25145493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Development of Tumor-Targeted Oral Anti-Cancer Prodrugs: Amino Acid and Dipeptide Monoester Prodrugs of Gemcitabine.
    Tsume Y; Drelich AJ; Smith DE; Amidon GL
    Molecules; 2017 Aug; 22(8):. PubMed ID: 28796151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.